Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5,859	3,348	2,186	2,097	3,039	1,383
Market Cap Growth	73.09%	53.13%	4.24%	-30.98%	119.78%	-10.37%
Enterprise Value	5,318	2,933	1,787	1,603	2,598	1,117
Last Close Price	55.92	32.48	20.31	19.80	26.16	12.10
PE Ratio	44.35	31.74	21.59	18.64	28.67	14.68
Forward PE	34.29	32.61	19.95	21.01	32.91	12.92
PS Ratio	9.16	6.94	5.44	5.73	8.59	4.51
PB Ratio	9.17	6.61	4.36	5.58	5.81	3.73
P/TBV Ratio	7.57	6.61	4.36	5.58	5.81	3.73
P/FCF Ratio	41.09	26.38	18.23	12.53	20.16	10.24
P/OCF Ratio	40.50	26.35	18.17	12.49	20.00	10.16
PEG Ratio	-	-	-	1.50	-	-
EV/Sales Ratio	8.46	6.08	4.45	4.38	7.34	3.64
EV/EBITDA Ratio	36.91	27.08	15.69	12.73	20.18	9.94
EV/EBIT Ratio	37.10	27.34	15.86	12.88	20.26	10.01
EV/FCF Ratio	37.29	23.12	14.90	9.58	17.24	8.27
Debt / Equity Ratio	0.01	0.00	0.00	0.00	0.00	0.01
Debt / EBITDA Ratio	0.05	0.00	0.01	0.00	0.02	0.03
Debt / FCF Ratio	0.05	0.00	0.01	0.00	0.02	0.03
Asset Turnover	0.91	0.80	0.80	0.74	0.72	0.85
Inventory Turnover	1.26	0.94	0.97	1.07	1.08	1.08
Quick Ratio	3.51	4.07	6.60	5.31	9.86	7.64
Current Ratio	3.70	4.39	6.89	5.60	10.07	7.91
Return on Equity (ROE)	25.77%	21.05%	23.11%	25.03%	23.70%	29.11%
Return on Assets (ROA)	13.00%	11.13%	13.98%	15.63%	16.29%	19.27%
Return on Capital (ROIC)	16.18%	13.28%	16.01%	17.25%	17.80%	21.45%
Earnings Yield	2.40%	3.17%	4.64%	5.36%	3.49%	6.81%
FCF Yield	2.43%	3.79%	5.48%	7.98%	4.96%	9.76%
Buyback Yield / Dilution	1.56%	3.64%	7.94%	-1.42%	-1.33%	3.25%
Total Shareholder Return	1.56%	3.64%	7.94%	-1.42%	-1.33%	3.25%

Source: S&P Capital IQ. Standard template. Financial Sources.